Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 17. November 2026
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 16913  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 338259  
   
Temporal Trends in High-Risk Benign Breast Disease Detection at Screening Mammography: Results from the Breast Cancer Surveillance Consortium.
Radiology
Sprague BL, Ponzini M, Sattayapiwat O, Eliassen MS, Nyante SJ, Tosteson ANA, Bowles EJA, Borowsky AD, Kerlikowske K, Lee CI, Perry H, Sowden M, Weaver DL, Miglioretti DL.
PMID: 43043180 [PubMed - indexed for MEDLINE]


Residual Pure Intralymphatic Breast Carcinoma After Neoadjuvant Therapy: Clinicopathologic Analysis and Comparative Outcomes Across Published Studies.
Arch Pathol Lab Med
Bahmad HF, Brachtel EF, Jorda M, Gomez-Fernández C, Tjendra Y.
PMID: 43042959 [PubMed - as supplied by publisher]


RE: SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis.
J Natl Cancer Inst
Mokbel K, Mokbel K.
PMID: 43042713 [PubMed - as supplied by publisher]


Neuroendocrine drivers of polyendocrine metabolic ovarian syndrome (PMOS) and the modifying role of adiposity.
J Neuroendocrinol
Kyriakidou A, Koysombat K, Comninos AN, Dhillo WS, Abbara A.
PMID: 43042610 [PubMed - indexed for MEDLINE]


Dual-target CAR-T cells in triple-negative breast cancer: recent advances and translational challenges.
Front Med (Lausanne)
Su J, Wang B, Xiao H, Zhang Y.
PMID: 43042313 [PubMed]


Regulation and Tumor-Promoting Functions of PD-L1 in Breast Cancer: Mechanisms, Tumor Microenvironment, and Therapeutic Implications.
Breast Cancer (Dove Med Press)
Xiang Y, Wu TW, Gao Y, Chen WQ, Lu ZX.
PMID: 43042303 [PubMed]


Histopathological Subtype and Cancer Stem Cell Marker Expression in Advanced Epithelial Ovarian Cancer: A Two-Year Progression-Free Survival Study.
World J Oncol
Budiana ING, Saspriyana KY.
PMID: 43042213 [PubMed]


Cutaneous and Breast Apocrine Carcinoma: A Diagnostic Dilemma Between Two Mimicking Malignancies Particularly in Axillary Tumors.
World J Oncol
Kawashima K, Matsushita R, Elsaedy EA, Oshi M, Yamada A, Narui K, Khoury T, Ishikawa T, Endo I, Takabe K.
PMID: 43042183 [PubMed]


Prevalence of Pathogenic Variants and Variants of Uncertain Significance in Patients With Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis.
Hum Mutat
Zhang W, Chen D, Zeng J, Yin R, Meng XY, Li Q.
PMID: 43042162 [PubMed - indexed for MEDLINE]


Impact of immersive virtual reality combined with lifestyle modification on upper limb function, pain intensity, and range of motion in post-surgical breast cancer survivors: A randomized controlled trial.
Pak J Med Sci
Irshad A, Babur MN, Umar M, Sultana B.
PMID: 43042128 [PubMed]


Correction: Determinants of self-reported sustained breast cancer screening among women in Shenzhen, China: a study based on the health belief model.
Front Public Health
Jin S, Ma X, Yang X, Zhang W, Li H, Gu Y, Wu B.
PMID: 43042028 [PubMed - in process]


Targeting the PI3K/AKT/mTOR pathway in endocrine-resistant, hormone receptor-positive, HER2-negative, advanced breast cancer.
EClinicalMedicine
Glaviano A, Abelman RO, Varkaris A, Varma S, McCann KE, Kumar AP, Diana P, de Bruin RAM, Juric D, Vasan N, Wander SA.
PMID: 43042018 [PubMed]


Efficacy of adding neoadjuvant pembrolizumab to standard chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis of real-world studies.
Pak J Med Sci
Qian X, Ruan L.
PMID: 43041967 [PubMed]


Neoadjuvant systemic therapy and the evolution of axillary management in breast cancer: a mini review and future directions.
Front Oncol
Lohita Krishna K, B S S.
PMID: 43041905 [PubMed]


VISTA as an emerging immune checkpoint in cervical cancer: spatial immune regulation, myeloid-T Cell crosstalk, and therapeutic opportunities.
Front Immunol
Li W, Wei W, Wen D, Aziz AUR, Yu X, Wang D, Ha C.
PMID: 43041860 [PubMed - indexed for MEDLINE]


The ovarian cellular ecosystem in polycystic ovary syndrome: from cellular heterogeneity to clinical relevance.
Front Endocrinol (Lausanne)
Ferk P, Lesko.
PMID: 43041639 [PubMed - indexed for MEDLINE]


NOTCH3/JAG1 signaling is associated with immunosuppressive tumor microenvironment features in ovarian cancer: links to nutritional risk, CD163+ macrophages, and CD8+ T cell exclusion.
Front Public Health
Zhu H, He Y, Hao R, Li X, Wang H.
PMID: 43041530 [PubMed - indexed for MEDLINE]


Effects of exercise interventions on cancer-related fatigue and quality of life in patients with metastatic breast cancer: a systematic review and meta-analysis.
Front Oncol
Zhou M, Zou L, Sun Z, Guo J.
PMID: 43041484 [PubMed]


Ocular adverse event profiles associated with endocrine therapies for breast cancer: a global pharmacovigilance study using FAERS and VigiAccess.
Front Oncol
Wang X, Zuo W, Zhang C, Liu B, Zhu B.
PMID: 43041374 [PubMed]


Peripheral absolute lymphocyte count and survival of patients with triple-negative breast cancer: a meta-analysis.
Front Oncol
Yang H, Ye C, Qin T, Lei Z, Rong Q, Zhou Y, Xie S, Lian B.
PMID: 43041327 [PubMed]


   
   Artikel 1 - 20 / 338259    Seite 1 von 16913  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1